Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.
Yee
David S
DS
Urology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Shariat
Shahrokh F
SF
Lowrance
William T
WT
Sterbis
Joseph R
JR
Vora
Kinjal C
KC
Bochner
Bernard H
BH
Donat
S Machele
SM
Herr
Harry W
HW
Dalbagni
Guido
G
Sandhu
Jaspreet S
JS
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D001918:Brachytherapy; D016009:Chi-Square Distribution; D003131:Combined Modality Therapy; D015653:Cystectomy; D018450:Disease Progression; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy* / Q000628:therapy; D018426:SEER Program; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology / Q000628:therapy*
D000726:Androgen Antagonists